Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD19 Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04788472
What this trial is testing

Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
Zhejiang University 28
Early research (Phase 1)Looking for participantsNCT07361029
What this trial is testing

CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed Refractory Acute Lymphoblastic Leukemia
King Faisal Specialist Hospital & Research Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT07222579
What this trial is testing

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

Who this might be right for
CD19 PositiveMixed Phenotype Acute Leukemia (MPAL)
West Virginia University 78
Testing effectiveness (Phase 2)UnknownNCT05381662
What this trial is testing

CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment

Who this might be right for
Acute Lymphoblastic Leukemia in Remission
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 10
Early research (Phase 1)Study completedNCT03029338
What this trial is testing

CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma

Who this might be right for
Lymphomas Non-Hodgkin's B-CellRelapse
Institute of Hematology & Blood Diseases Hospital, China 20
Very early researchLooking for participantsNCT07312630
What this trial is testing

Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Acute Lymphoblastic Leukemia (ALL), Adult
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 19
Early research (Phase 1)UnknownNCT02822326
What this trial is testing

Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia

Who this might be right for
Acute Leukemia
Guangdong Provincial People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05800210
What this trial is testing

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaJuvenile Myelomonocytic Leukemia+4 more
University of Florida 20
Early research (Phase 1)Looking for participantsNCT06752785
What this trial is testing

CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.

Who this might be right for
Acute Lymphoblastic Leukemia
Guangzhou Women and Children's Medical Center 10
Very early researchNot Yet RecruitingNCT05779930
What this trial is testing

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma Refractory+3 more
Nationwide Children's Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT07252336
What this trial is testing

Study of CAR-T Cells in Primary Ph+All

Who this might be right for
ALL
Zhejiang University 50
Very early researchUnknownNCT04184414
What this trial is testing

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaMantle Cell LymphomaFollicular Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Looking for participantsNCT06179524
What this trial is testing

CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL

Who this might be right for
Relapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia
Beijing Yongtai Ruike Biotechnology Company Ltd 100
Early research (Phase 1)Active Not RecruitingNCT00840853
What this trial is testing

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Chronic Lymphocytic Leukemia (CLL)Non Hodgkin's Lymphoma
Baylor College of Medicine 68
Testing effectiveness (Phase 2)Study completedNCT01475058
What this trial is testing

CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

Who this might be right for
Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia+4 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05460533
What this trial is testing

A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 30
Early research (Phase 1)Study completedNCT02746952
What this trial is testing

Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Institut de Recherches Internationales Servier 25
Testing effectiveness (Phase 2)Study completedNCT04605666
What this trial is testing

CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies

Who this might be right for
B Cell LeukemiaB Cell Lymphoma
Nanfang Hospital, Southern Medical University 77
Early research (Phase 1)Study completedNCT01805375
What this trial is testing

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

Who this might be right for
Indolent B-cell LymphomaChronic Lymphocytic LeukaemiaWaldenström Macroglobulinaemia
Cancer Research UK 28
Early research (Phase 1)UnknownNCT03798509
What this trial is testing

Human CD19 Targeted T Cells Injection Therapy for Relapsed and Refractory CD19-positive Leukemia

Who this might be right for
CD19-positiveAcute Lymphoblastic Leukemia
Hrain Biotechnology Co., Ltd. 18
Next Page